SCHEMBL8869141

SCHEMBL8869141

CCCOC(=O)CNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(C(=O)NCCOCC)cc2)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 3/20 0.45
POLB P06746 1/20 0.42
EGFR P00533 2/20 0.41
KMT2A Q03164 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
MEN1 O00255 1/20 0.38
CA2 P00918 2/20 0.37
CA1 P00915 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
HPGD P15428 2/20 0.37
FLT1 P17948 1/20 0.37
FLT4 P35916 1/20 0.37
KDR P35968 1/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868067 0.95 HPGD (0.44) P4HTMPOLBEGFRKMT2ATDP1
SCHEMBL8867993 0.95 P4HTM (0.46) P4HTMPOLBEGFRTDP1CA2
SCHEMBL8868717 0.93 P4HTM (0.48) P4HTMPOLBEGFRKMT2ATDP1
SCHEMBL8869447 0.92 P4HTM (0.49) P4HTMPOLBEGFRKMT2AMEN1
SCHEMBL8869147 0.91 P4HTM (0.46) P4HTMPOLBEGFRKMT2ATDP1
SCHEMBL8869631 0.91 P4HTM (0.53) P4HTMEGFRKMT2ACA2SMN1; SMN2
SCHEMBL8867726 0.90 P4HTM (0.48) P4HTMPOLBEGFRKMT2ATDP1
SCHEMBL8868602 0.90 NPC1 (0.51) P4HTMPOLBKMT2AMEN1CA2
SCHEMBL8870231 0.89 CA2 (0.47) P4HTMPOLBEGFRKMT2ATDP1
SCHEMBL8868825 0.89 HPGD (0.46) P4HTMPOLBEGFRKMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed